also consider using these proteins as a conjugate to transporting drugs to specific tissues by means of endothelial address.
mm093, ATryn, rhAAT, and don't forget antibodies.
using technology to target a potentially toxic small molecule drug to a tissue, reducing toxicity issues opens up many more compounds for many more applications. That's how I see small molecule pharma could use some of these proteins.
Market Data 
Markets 
AI
